Learning Center

Learning Center

Atypical Femur Fracture Identification and Prevention (On-Demand)

  • Register
    • Non-Member - $35
    • Full Member - Free!
    • MOC Only - $35
    • Community Member - $35
    • Professional Member - $35

Activity approved for 1.00 AMA PRA Category 1 Credits™ 
Activity approved for 1.5 ASRT Category A Credits
Activity Expires July 14, 2027

Activity Description

AFFs are associated with some osteoporosis treatments and may occur without any treatment. The risk of AFF for most patients is very low and can be minimized with appropriate care. This presentation will address strategies for early recognition AFF, treatment of incomplete and complete AFF, and management of osteoporosis after AFF.

Learning Objectives

  1. Identify standards for diagnosing atypical femur fractures (AFF)
  2. Describe risk factors for AFF
  3. Discuss strategies for prevention of AFF
  4. Review the risks, epidemiological patterns, and clinical features of atypical femoral fractures (AFFs).
  5. Discuss differential management of AFF linked to bisphosphonate or denosumab therapy, including areas of uncertainty.
  6. Evaluate the clinical implications of current AFF knowledge in the context of anti-osteoporosis pharmacotherapy.


Instructions

Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

Registration Fees

image


Cancellation Policy

On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.

On-Demand/Enduring Material Program Changes or Cancellations 
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Joint Accreditation Statement

image

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASRT Credit Designation 

This activity has been approved by ASRT for 1.5 Category A continuing education credits.

Date of Original Release and most recent Review or Update 

This activity was most recently reviewed and released on July 15th, 2026.

E. Michael Lewiecki, MD, FACP, FACE, CCD

E. Michael Lewiecki, MD, FACP, FACE, CCD

Director

New Mexico Clinical Research & Osteoporosis Center, Inc.

E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

WuQiang Fan, MD, PhD

WuQiang Fan, MD, PhD

Director of Fracture Liaison Service, Assistant Professor of Medicine

Massachusetts General Hospital, Harvard Medical School

Dr. WuQiang Fan (pronounced as “Wu-Chiang Fan”) earned his medical degree from Zhejiang University School of Medicine in China. He subsequently completed his PhD in molecular biology at Kyushu University in Japan, where he investigated steroid hormone receptor signaling and transcriptional regulation. He then pursued postdoctoral research on diabetes and insulin signaling at the University of California, San Diego School of Medicine, before undertaking internal medicine residency training at Drexel University College of Medicine. In 2016, he began his endocrinology fellowship at Massachusetts General Hospital (MGH), where he remained on faculty following graduation. His clinical interests focus on metabolic bone disease and diabetes. He currently serves as Director of the MGH Fracture Liaison Service and Fracture Secondary Prevention Program, and as one of the Associate Program Directors of the MGH Endocrinology Fellowship Training Program. He is an Assistant Professor of Medicine at Harvard Medical School.

image

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use 

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendee Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

Course Changes or Cancellations

ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Components visible upon registration.